Literature DB >> 7106185

Binding of a specific 5-HT uptake inhibitor, [3H]norzimelidine, to rat brain homogenates.

H Hall, S Ross, S O Ogren, L Gawell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7106185     DOI： 10.1016/0014-2999(82)90071-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  3 in total

1.  Regional studies of serotonin and dopamine metabolism and quantification of serotonin uptake sites in human cerebral cortex.

Authors:  B Parsons; A Roxas; Y Y Huang; A Dwork; M Stanley
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 2.  Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R C Heel; P A Morley; R N Brogden; A A Carmine; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

3.  Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementia.

Authors:  S O Ogren; A C Holm; H Hall; U H Lindberg
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.